Search
for
Sort by
Research 421–450 of 1000+
- Advances in Vitiligo Treatment
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- 455 Beyond Immunity: TEC and JAK3 Kinase Activation in Melanocytes Drives Inflammation in Vitiligo
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023
- Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- The correlation between corona virus disease 2019 and alopecia areata: a literature review
- Is Wnt5a overexpression sufficient for generating a psoriasis‐like phenotype in transgenic mice?
- PV-0538 Prostaglandin related distinct regenerative activities in hair follicles following radiation injury
- The skin and vitamin D
- Research Progress on Fractional CO<sub>2</sub> Laser in Multimodal Therapy
- Role of Non Androgenic Factors in Hair loss and Hair Regrowth
- PLAU and SerpinB2 role in apoptosis in leprosy
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- At the crossroads of 2 alopecias: Androgenetic alopecia pattern of hair regrowth in patients with alopecia areata treated with oral Janus kinase inhibitors
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Janus kinase inhibitors for alopecia areata: a review of clinical data